Long term antipsychotic polypharmacy is common among Medicaid recipients with schizophrenia

The survey included only two state databases, and they varied significantly in the incidence of long term antipsychotic polypharmacy (29.3% in California v 18.1% in Georgia). [...]care should be taken in generalising these findings. [...]in Los Angeles County there are 240 state hospital beds for about 3 million people. [...]physicians may feel that polypharmacy is the only option available to them in patients showing limited response to monotherapy, even though they know it may not work.